Información de cbdMD Inc, dividendo de cbdMD Inc, actividades de los accionistas y más

Más Datos de cbdMD Inc Compañía

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

Información de cbdMD Inc



Símbolo de cotizaciónYCBD

Nombre de la empresacbdMD Inc

Fecha de salida a bolsaNov 17, 2017

Director ejecutivoKennedy (T. Ronan)

Número de empleados42

Tipo de seguridadOrdinary Share

Fin del año fiscalNov 17

Dirección8845 Red Oak Blvd

CiudadCHARLOTTE

Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex

PaísUnited States of America

Código postal28217-5593

Teléfono17044453060

Sitio Webhttps://www.cbdmd.com/

Símbolo de cotizaciónYCBD

Fecha de salida a bolsaNov 17, 2017

Director ejecutivoKennedy (T. Ronan)

Ejecutivos de cbdMD Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Scott G. Stephen

Independent Chairman of the Board

3.41K

+46.14%

Mr. Bakari T. Sellers

Independent Director

3.32K

+47.35%

Mr. William F. Raines, III

Independent Director

--

Mr. T. Ronan Kennedy

Chief Executive Officer, Chief Financial Officer, Director

--

Dr. Sibyl Swift

Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director

--

Mr. Bradley Whitford

Chief Accounting Officer, Treasurer, Company Secretary

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Scott G. Stephen

Independent Chairman of the Board

3.41K

+46.14%

Mr. Bakari T. Sellers

Independent Director

3.32K

+47.35%

Mr. William F. Raines, III

Independent Director

--

Mr. T. Ronan Kennedy

Chief Executive Officer, Chief Financial Officer, Director

--

Dr. Sibyl Swift

Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director

--

Mr. Bradley Whitford

Chief Accounting Officer, Treasurer, Company Secretary

--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

Por negocioUSD

Nombre

Ganancia

Proporción

E-commerce sales

3.60M

71.79%

Wholesale sales

1.42M

28.21%

La empresa aún no ha revelado los datos relevantes.

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

E-commerce sales

3.60M

71.79%

Wholesale sales

1.42M

28.21%

Estadísticas de accionistas

Actualizado: mié., 13 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

Porter (Jeffrey H)

5.49%

Crc Investment Fund LP

4.16%

Worth Venture Partners, LLC

2.56%

UBS Financial Services, Inc.

1.57%

CSS, LLC

1.35%

Otro

84.88%

Accionistas

Proporción

Porter (Jeffrey H)

5.49%

Crc Investment Fund LP

4.16%

Worth Venture Partners, LLC

2.56%

UBS Financial Services, Inc.

1.57%

CSS, LLC

1.35%

Otro

84.88%

Tipos de accionistas

Accionistas

Proporción

Individual Investor

6.52%

Investment Advisor

5.75%

Corporation

4.16%

Investment Advisor/Hedge Fund

2.57%

Research Firm

0.90%

Hedge Fund

0.02%

Otro

80.09%

Participación institucional



Actualizado: mié., 1 de abr

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2026Q4

33

436.16K

5.38%

--

2026Q1

53

1.07M

10.17%

+518.29K

2025Q4

53

457.02K

4.35%

-122.38K

2025Q3

51

502.25K

5.64%

+188.29K

2025Q2

61

1.71M

19.14%

+1.55M

2025Q1

80

154.62K

3.22%

-19.13K

2024Q4

76

811.68K

23.02%

+42.15K

2024Q3

80

869.63K

30.51%

+134.84K

2024Q2

85

734.40K

27.03%

-50.91K

2024Q1

91

757.62K

28.39%

-18.50K

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Porter (Jeffrey H)

574.71K

5.48%

--

Feb 02, 2026

Crc Investment Fund LP

436.15K

4.16%

-797.41K

-64.64%

Dec 17, 2025

Worth Venture Partners, LLC

268.29K

2.56%

+268.29K

--

Dec 31, 2025

UBS Financial Services, Inc.

10.15K

0.1%

+10.14K

+101410.00%

Dec 31, 2025

CSS, LLC

141.62K

1.35%

-1.00K

-0.70%

Dec 31, 2025

Chapin Davis Asset Management

81.25K

0.77%

-40.30K

-33.15%

Dec 31, 2025

Jane Street Capital, L.L.C.

51.14K

0.49%

+51.14K

--

Dec 31, 2025

Kennedy (Thomas Ronan)

68.72K

0.65%

--

Feb 02, 2026

Alesco Advisors LLC

68.51K

0.65%

--

Dec 31, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

Cambria Cannabis ETF

0%

iShares Core S&P Total U.S. Stock Market ETF

0%

Amplify Seymour Cannabis ETF

0%

Cambria Cannabis ETF

Proporción0%

iShares Core S&P Total U.S. Stock Market ETF

Proporción0%

Amplify Seymour Cannabis ETF

Proporción0%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Apr 21, 2025

Merger

8→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Fecha

Fecha ex-dividendo

Tipo

Relación

Apr 21, 2025

Merger

8→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1